The recommended range for researchers on GLP-1 medications is 1.6-2.2 grams per kilogram of body weight daily
If the goal is unrealistic, clinically inappropriate, or no longer relevant, the percentage can create pressure rather than clarity
92,93 Additionally, NAD+ precursors, such as nicotinamide riboside and nicotinamide mononucleotide, may hypothetically synergize with GLP-1R signaling to enhance mitochondrial function and cellular resilience, although the extent of these interactions remains untested in humans
Customer support can be slow
Diabetes, Obesity and Metabolism, 22(6), pp.10081018
Large clinical trials such as LEADER and SUSTAIN-6 have not identified increased fracture risk with GLP-1 therapy compared to placebo